Skip to main content

Table 1 Demographic, clinical, and symptom characteristics of patients with delirium who responded to fluvoxamine

From: Sigma-1 receptor agonist fluvoxamine for delirium in intensive care units: report of five cases

Case

Gender (F/M)

Age (years)

Diagnosis

Dose of fluvoxamine

DRS before treatment

DRS after treatment

1

M

84

Acute aortic association

50 mg

16/32

6/32 (1 day)

2

M

55

Traumatic subarachnoid hemorrhage, brain contusion

50 mg

20/32

10/32 (1 day)

3

M

76

Sepsis by pyelonephritis

50-150 mg

21/32

10/32 (3 days)

4

M

85

Cerebral infarction

50 mg

19/32

10/32 (1 day)

5

M

86

Pulmonary emphysema, severe pneumonia

50-100 mg

18/32

6/32 (2 days)

  1. DRS = Delirium Rating Scale.